Meet the Queen of Alk, Dr. Alice Shaw. Join Dr. Shaw and Gina Hollenbeck for an informal chat as they discuss Dr. Shaw's take on how treatment for the ALK Positive mutation has evolved and where it is going. Bone metastasis, pregnancies and fertility while taking tki's, and treatment dosing are just a few of the topics covered. Dr. Alice Shaw worked for over 15 years at Massachusetts General Hospital as a clinical trial investigator. She helped lung cancer evolve from a disease with few options, to one of hope with clinically proven therapies. Dr. Shaw continues to push the envelope as the Global Head of Translational Clinical Oncology at the Novartis Institutes for BioMedical Research. WATCH VIDEO
ALK Positive Inc
Authors: Dr. Alice Shaw
Watch to learn how ALK Positive patients can take an active role in accelerating ALK research. Research is what improves our life expectancy and gives us hope. "The purpose of this research study is to obtain and study tissue, saliva, and blood specimens from patients with ALK-positive lung cancer, along with clinical trial information about their disease and treatment. The overall goal is to enhance understanding of the biology of ALK-positive lung cancer."
ALK Positive Inc.
AUTHORS: Dr. Gainor and Dr. Lin
Read MoreDr. Gadgeel brings brilliance, compassion and hope to ALKtALK. This talk offers the history of the ALK Positive mutation, the evolutions of its treatments, and current trials- including ADC and TIL Therapy. WATCH VIDEO
ALK Positive Inc.
Authors: Shirish Gadgeel
Karen Reckamp, MD, and Jyoti Patel, MD, outline their treatment approaches for patients with ALK+ NSCLC who progress on frontline TKIs. WATCH VIDEO
Targeted Oncology
Authors: Karen Reckamp, Jyoti Patel
Research progress
Learn about the many programs ALK Positive, Inc. Medical Committee has created to accelerate ALK research from Colin Barton and other medical committee members
ALK Positive Inc.
AUTHORS: Colin Barton & others
Read MoreBattling cancer and simultaneously celebrating the holidays can be tricky waters to navigate. While feeling grateful to continue traditions with family and friends many also experience being overwhelmed, anxious or depressed. This ALKtALK not only validates these feelings, but provides coping skills to help survive and thrive during this upcoming holiday season. WATCH VIDEO
ALK Positive Inc.
AUTHOR: Dr. Schurgin
Read MoreDr. Ignatius Ou speaks to the ALK Positive community about how he came to study ALK. He gives a presentation about variants and describes his clinical practices. He educates the ALK community about everything from ALK trials to surgery for stage IV patients. WATCH VIDEO
ALK Positive Inc.
Authors: Dr. Ignatius Ou
Dr. Laura Petrillo speaks to the ALK Positive community about Palliative Care. Some website of interest: getpalliativecare.org, https://www.mghpact.org/
Here is the ASCO guideline recommending the early integration of palliative care, cites a lot of evidence and includes information about the domains of palliative care:https://ascopubs.org/doi/full/10.1200/JCO.2016.70.1474
Cancer.net also has a nice section on what palliative care is: https://www.cancer.net/coping-with-cancer/physical-emotional-and-social-effects-cancer/what-palliative-care WATCH VIDEO
ALK Positive Inc.
Authors: Laura Petrillo
Welcome to day 2 of ALK Summit 2021: STRONGER TOGETHER and keynote speaker, Tasneeem Ahmed talks about where the ALK space is today and the HOPE we have for the future with Q&A from the ALK Community. WATCH VIDEO
ALK Positive Inc.
Authors: Amanda Nerstad, Bill Westlake and Tasneem Ahmed
Read MoreALK Summit 2021: STRONGER TOGETHER: Research Funded by ALK Positive- Hear From the Researchers Mark Awad, Trever Bivona, Roberto Chiarle, Ibiayi Dagogo- Jack, Juston Gainor, John Iafrate, Christine Lovly, Raphael Nemenoff. Moderators: Colin Barton and Emily Venanzi WATCH VIDEO
ALK Positive Inc.
Authors: Mark Awad, Trever Bivona, Roberto Chiarle, Ibiayi Dagogo- Jack, Juston Gainor, John Iafrate, Christine Lovly and Raphael Nemenoff
Read MoreALK Summit 2021: STRONGER TOGETHER. What is Next After Lorlatinib? 4th Generation TKI’s and Beyond Speakers: dr. Ross Camidge, MD, PHD University of Colorado Cancer Center, Dr. Christine Lovly, MD PhD, BA Vanderbilt- Ingram Cancer Center. Moderator(s): Colin Barton, Emily Vennzi. Dr. Ross Camidge and Dr. Christine Lovly speak about the many treatment options that are available NOW if a patient experiences progression on Lorlatinib. Even more exciting, they speak about what's already visible on the horizon for new treatments that could transform our future. WATCH VIDEO
ALK Positive Inc.
Authors: Dr. Ross Camidge and Dr. Christine Lovly
Read MoreALK summit 2021: Benefits of a Multi-Disciplinary Team: Stronger Together Dr. Ross Camidge, MD, PhD University of Colorado Cancer Center, Dr. Vicent Lam, MDAssistant Professor of Oncology, Johns Hopkins University, Dr. Drew Maghanaki, MD, MPH, UCLA Department of Radiation Oncology, Dr. Brendon Stiles, MD, Professor and Chief of Thoracic Surgery Oncology Montefiore Health System, Dr. Laura Petrilo, MD, Palliative Care at Massachusetts General Hospital Moderator: Amanda Nerstad, ALK Summit Chair. WATCH VIDEO
ALK Positive Inc.
Authors: Dr. Ross Camidge, Dr. Vicent Lam, Dr. Drew Maghanaki, Dr. Brendon Stiles, Dr. Laura Petrilo and Amanda Nerstad
Read MoreWATCH VIDEO
Vumedi
Authors: Malinda Itchins
WATCH VIDEO
Vumedi
Authors: Malinda Itchins